相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Sepsis and Septic Shock Definitions in Patients With Cancer Admitted in ICU
Neveux Nathan et al.
JOURNAL OF INTENSIVE CARE MEDICINE (2021)
Prognostic performance of qSOFA in oncology patients admitted to the emergency department with suspected infection
Tze Lui Koh et al.
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2021)
Inappropriate empirical antibiotic therapy for bloodstream infections based on discordant in-vitro susceptibilities: a retrospective cohort analysis of prevalence, predictors, and mortality risk in US hospitals
Sameer S. Kadri et al.
LANCET INFECTIOUS DISEASES (2021)
Inappropriate Empirical Antibiotic Treatment in High-risk Neutropenic Patients With Bacteremia in the Era of Multidrug Resistance
Gemma Martinez-Nadal et al.
CLINICAL INFECTIOUS DISEASES (2020)
Long-term prognosis of septic shock in cancer patients
Fabrice Camou et al.
SUPPORTIVE CARE IN CANCER (2020)
A Randomized, Double-Blind, Placebo-Controlled Trial (TAURCAT Study) of Citrate Lock Solution for Prevention of Endoluminal Central Venous Catheter Infection in Neutropenic Hematological Patients
Carlota Gudiol et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Antibiotic prescribing and outcomes in cancer patients with febrile neutropenia in the emergency department
Olivier Peyrony et al.
PLOS ONE (2020)
Sepsis and Septic Shock in Patients With Malignancies: A Groupe de Recherche Respiratoire en Reanimation Onco-Hematologique Study*
Virginie Lemiale et al.
CRITICAL CARE MEDICINE (2020)
Efficacy of extended infusion of β-lactam antibiotics for the treatment of febrile neutropenia in haematologic patients: protocol for a randomised, multicentre, open-label, superiority clinical trial (BEATLE)
J. Laporte-Amargos et al.
TRIALS (2020)
Febrile neutropenia in patients with acute myeloid leukemia: Outcome in relation to qSOFA score, C-reactive protein, and blood culture findings
Marika Lappalainen et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2020)
One-year survival in patients with solid tumours discharged alive from the intensive care unit after unplanned admission: A retrospective study
Edith Borcoman et al.
JOURNAL OF CRITICAL CARE (2020)
Treatment of extended-spectrum β-lactamases infections: what is the current role of new β-lactams/β-lactamase inhibitors?
Matteo Bassetti et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2020)
Utility of procalcitonin as a predictor of bloodstream infections and supportive modality requirements in critically ill cancer patients
Amanda G. Blouin et al.
CLINICA CHIMICA ACTA (2020)
Incidence and clinical course of septic shock in neutropenic patients during chemotherapy for gynecological cancers
Jigeun Yoo et al.
JOURNAL OF GYNECOLOGIC ONCOLOGY (2020)
Bloodstream infection in patients with head and neck cancer: a major challenge in the cetuximab era
M. Marin et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2019)
Sepsis and Risk of Cancer Among Elderly Adults in the United States
Zhiwei Liu et al.
CLINICAL INFECTIOUS DISEASES (2019)
Extended Infusion of Broad-spectrum β-Lactams in High-risk Febrile Neutropenic Patients
Carlota Gudiol et al.
CLINICAL INFECTIOUS DISEASES (2019)
Mechanisms of high-level ceftolozane/tazobactam resistance in Pseudomonas aeruginosa from a severely neutropenic patient and treatment success from synergy with tobramycin
Wonhee So et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2019)
Cutting Edge: Polymicrobial Sepsis Has the Capacity to Reinvigorate Tumor-Infiltrating CD8 T Cells and Prolong Host Survival
Derek B. Danahy et al.
JOURNAL OF IMMUNOLOGY (2019)
Epidemiology and Outcomes of Cancer-Related Versus Non-Cancer-Related Sepsis Hospitalizations*
Matthew K. Hensley et al.
CRITICAL CARE MEDICINE (2019)
Rescue stem cell allograft in intensive care unit patients during septic shock with multi-organ failure
Perrine Lepretre et al.
JOURNAL OF CRITICAL CARE (2019)
A toll-like receptor agonist mimicking microbial signal to generate tumor-suppressive macrophages
Yanxian Feng et al.
NATURE COMMUNICATIONS (2019)
Sepsis inhibits tumor growth in mice with cancer through Toll-like receptor 4-associated enhanced Natural Killer cell activity
Clara Vigneron et al.
ONCOIMMUNOLOGY (2019)
Shock and Early Death in Hematologic Patients with Febrile Neutropenia
Mariana Guarana et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Comparison of Presepsin, Procalcitonin, Interleukin-8 and C-Reactive Protein in Predicting Bacteraemia in Febrile Neutropenic Adult Patients with Haematological Malignancies
Irena Kostic et al.
MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES (2019)
Contribution of specific pathogens to bloodstream infection mortality in neutropenic patients with hematologic malignancies: Results from a multicentric surveillance cohort study
Winfried Kern et al.
TRANSPLANT INFECTIOUS DISEASE (2019)
Ceftazidime-avibactam for gram-negative multidrug-resistant bacteria in hematological patients: a single-center experience
Elisabetta Metafuni et al.
ANNALS OF HEMATOLOGY (2019)
A Case-Control Study of Real-Life Experience with Ceftolozane-Tazobactam in Patients with Hematologic Malignancy and Pseudomonas aeruginosa Infection
Ana Fernandez-Cruz et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Successful Treatment of Bacteremia Due to NDM-1-Producing Morganella morganii with Aztreonam and Ceftazidime-Avibactam Combination in a Pediatric Patient with Hematologic Malignancy
Claire Amaris Hobson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Serum procalcitonin as an independent diagnostic markers of bacteremia in febrile patients with hematologic malignancies
Mina Yang et al.
PLOS ONE (2019)
Determinants of 1-year survival in critically ill acute leukemia patients: a GRRR-OH study
Marcio Tavares et al.
LEUKEMIA & LYMPHOMA (2018)
Extended infusion compared to standard infusion cefepime as empiric treatment of febrile neutropenia
Rebekah H. Wrenn et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE (2018)
Bloodstream infections in haematological cancer patients colonized by multidrug-resistant bacteria
C. Cattaneo et al.
ANNALS OF HEMATOLOGY (2018)
Extended vs Bolus Infusion of Broad-Spectrum β-Lactams for Febrile Neutropenia: An Unblinded, Randomized Trial
Ron Ram et al.
CLINICAL INFECTIOUS DISEASES (2018)
Urgent Chemotherapy in Sepsis-Like Shock Related to Hematologic Malignancies
Marlene Cherruault et al.
CRITICAL CARE MEDICINE (2018)
Ceftolozane-tazobactam therapy for multidrug-resistant Pseudomonas aeruginosa infections in patients with hematologic malignancies and hematopoietic-cell transplant recipients
Morgan Hakki et al.
INFECTION (2018)
Clinical characteristics and outcomes of cancer patients requiring intensive care unit admission: a prospective study
Frank Daniel Martos-Benitez et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2018)
Prolonged versus short-term intravenous infusion of antipseudomonal beta-lactams for patients with sepsis: a systematic review and meta-analysis of randomised trials
Konstantinos Z. Vardakas et al.
LANCET INFECTIOUS DISEASES (2018)
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
Andrew Rhodes et al.
INTENSIVE CARE MEDICINE (2017)
Clinical efficacy of ceftazidime/avibactam versus other active agents for the treatment of bacteremia due to carbapenemase-producing Enterobacteriaceae in hematologic patients
Juan J. Caston et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2017)
Optimisation of empirical antimicrobial therapy in patients with haematological malignancies and febrile neutropenia (How Long study): an open-label, randomised, controlled phase 4 trial
Manuela Aguilar-Guisado et al.
LANCET HAEMATOLOGY (2017)
Time Course of Septic Shock in Immunocompromised and Nonimmunocompromised Patients
Matthieu Jamme et al.
CRITICAL CARE MEDICINE (2017)
Antimicrobial Resistance in Gram-Negative Rods Causing Bacteremia in Hematopoietic Stem Cell Transplant Recipients: Intercontinental Prospective Study of the Infectious Diseases Working Party of the European Bone Marrow Transplantation Group
Diana Averbuch et al.
CLINICAL INFECTIOUS DISEASES (2017)
Characteristics and Outcome of Cancer Patients Admitted to the ICU in England, Wales, and Northern Ireland and National Trends Between 1997 and 2013
Marlies Ostermann et al.
CRITICAL CARE MEDICINE (2017)
New agents for the treatment of infections with Gram-negative bacteria: restoring the miracle or false dawn?
H. Wright et al.
CLINICAL MICROBIOLOGY AND INFECTION (2017)
Short-Course Adjunctive Gentamicin as Empirical Therapy in Patients With Severe Sepsis and Septic Shock: A Prospective Observational Cohort Study
David S. Y. Ong et al.
CLINICAL INFECTIOUS DISEASES (2017)
Carbapenem-resistant Klebsiella pneumoniae in high-risk haematological patients: factors favouring spread, risk factors and outcome of carbapenem-resistant Klebsiella pneumoniae bacteremias
Alessandra Micozzi et al.
BMC INFECTIOUS DISEASES (2017)
Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey
Enrico Maria Trecarichi et al.
AMERICAN JOURNAL OF HEMATOLOGY (2016)
Continuous versus Intermittent β-Lactam Infusion in Severe Sepsis A Meta-analysis of Individual Patient Data from Randomized Trials
Jason A. Roberts et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2016)
Toxicities of chimeric antigen receptor T cells: recognition and management
Jennifer N. Brudno et al.
BLOOD (2016)
The immune system's role in sepsis progression, resolution, and long-term outcome
Matthew J. Delano et al.
IMMUNOLOGICAL REVIEWS (2016)
Carbapenemase-producing Klebsiella pneumoniae bloodstream infections in neutropenic patients with haematological malignancies or aplastic anaemia: Analysis of 50 cases
Polydoros Tofas et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2016)
Developing a New Definition and Assessing New Clinical Criteria for Septic Shock For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
Manu Shankar-Hari et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Incidence, Risk Factors, and Attributable Mortality of Secondary Infections in the Intensive Care Unit After Admission for Sepsis
Lonneke A. van Vught et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Assessment of Clinical Criteria for Sepsis For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
Christopher W. Seymour et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
Mervyn Singer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Effects of Organizational Characteristics on Outcomes and Resource Use in Patients With Cancer Admitted to Intensive Care Units
Marcio Soares et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Bacteremia due to carbapenem-resistant Enterobacteriaceae in neutropenic patients with hematologic malignancies
Michael J. Satlin et al.
JOURNAL OF INFECTION (2016)
Bacterial Sepsis Increases Survival in Metastatic Melanoma: Chlamydophila Pneumoniae Induces Macrophage Polarization and Tumor Regression
Krisztina Buzas et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2016)
Use of Ceftolozane/Tazobactam in the Treatment of Multidrug-resistant Pseudomonas aeruginosa Bloodstream Infection in a Pediatric Leukemia Patient
Samuel L. Aitken et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2016)
Bloodstream infections in patients with solid tumors
Carlota Gudiol et al.
VIRULENCE (2016)
Post-Sepsis State Induces Tumor-Associated Macrophage Accumulation through CXCR4/CXCL12 and Favors Tumor Progression in Mice
Jose M. Mota et al.
CANCER IMMUNOLOGY RESEARCH (2016)
Septic shock with no diagnosis at 24 hours: a pragmatic multicenter prospective cohort study
Damien Contou et al.
CRITICAL CARE (2016)
Neutropenic Enterocolitis New Insights Into a Deadly Entity
Taha Sachak et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2015)
Diagnostic and prognostic role of procalcitonin (PCT) and MR-pro-Adrenomedullin (MR-proADM) in bacterial infections
Silvia Angeletti et al.
APMIS (2015)
Managing critically Ill hematology patients: Time to think differently
Elie Azoulay et al.
BLOOD REVIEWS (2015)
Current epidemiology and antimicrobial resistance data for bacterial bloodstream infections in patients with hematologic malignancies: an Italian multicentre prospective survey
E. M. Trecarichi et al.
CLINICAL MICROBIOLOGY AND INFECTION (2015)
Factors influencing mortality in neutropenic patients with haematologic malignancies or solid tumours with bloodstream infection
M. Marin et al.
CLINICAL MICROBIOLOGY AND INFECTION (2015)
Severe Sepsis in Hematopoietic Stem Cell Transplant Recipients
Gagan Kumar et al.
CRITICAL CARE MEDICINE (2015)
Effect of Early Intervention on Long-Term Outcomes of Critically Ill Cancer Patients Admitted to ICUs
Dae-Sang Lee et al.
CRITICAL CARE MEDICINE (2015)
The Epidemiology of Chronic Critical Illness in the United States
Jeremy M. Kahn et al.
CRITICAL CARE MEDICINE (2015)
Prognosis of neutropenic patients admitted to the intensive care unit
D. Mokart et al.
INTENSIVE CARE MEDICINE (2015)
Organizational characteristics, outcomes, and resource use in 78 Brazilian intensive care units: the ORCHESTRA study
Marcio Soares et al.
INTENSIVE CARE MEDICINE (2015)
Does procalcitonin, C-reactive protein, or interleukin-6 test have a role in the diagnosis of severe infection in patients with febrile neutropenia? A systematic review and meta-analysis
Chun-Wei Wu et al.
SUPPORTIVE CARE IN CANCER (2015)
Timing and causes of death in septic shock
Fabrice Daviaud et al.
ANNALS OF INTENSIVE CARE (2015)
Sepsis-Associated Outcomes in Critically Ill Patients with Malignancies
Viviane B. L. Torres et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2015)
Prognostic factors, long-term survival, and outcome of cancer patients receiving chemotherapy in the intensive care unit
Philipp Wohlfarth et al.
ANNALS OF HEMATOLOGY (2014)
Lymphocyte recovery is impaired in patients with chronic lymphocytic leukemia and indolent non-Hodgkin lymphomas treated with bendamustine plus rituximab
Ricardo Garcia Munoz et al.
ANNALS OF HEMATOLOGY (2014)
The Utility of Proadrenomedullin and Procalcitonin in Comparison to C-Reactive Protein as Predictors of Sepsis and Bloodstream Infections in Critically III Patients With Cancer
Labib Debiane et al.
CRITICAL CARE MEDICINE (2014)
Exploring the Scope of Post-Intensive Care Syndrome Therapy and Care: Engagement of Non-Critical Care Providers and Survivors in a Second Stakeholders Meeting
Doug Elliott et al.
CRITICAL CARE MEDICINE (2014)
Antibiotic resistance in cancer patients
Carlota Gudiol et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2014)
De-escalation of antimicrobial treatment in neutropenic patients with severe sepsis: results from an observational study
Djamel Mokart et al.
INTENSIVE CARE MEDICINE (2014)
Effect of meropenem administration in extended infusion on the clinical outcome of febrile neutropenia: a retrospective observational study
Csaba Feher et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Respiratory events at the earliest phase of acute myeloid leukemia
Anne-Sophie Moreau et al.
LEUKEMIA & LYMPHOMA (2014)
Beta lactam antibiotic monotherapy versus beta lactamaminoglycoside antibiotic combination therapy for sepsis
Mical Paul et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2014)
Pro-adrenomedullin as a Novel Biomarker for Predicting Infections and Response to Antimicrobials in Febrile Patients With Hematologic Malignancies
Munirah Al Shuaibi et al.
CLINICAL INFECTIOUS DISEASES (2013)
Profile of the Risk of Death After Septic Shock in the Present Era: An Epidemiologic Study
Arnaud Pavon et al.
CRITICAL CARE MEDICINE (2013)
European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia
Diana Averbuch et al.
HAEMATOLOGICA (2013)
Epidemiology and clinical outcomes of bloodstream infections caused by extended-spectrum β-lactamase-producing Escherichia coli in patients with cancer
Young Eun Ha et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2013)
Outcomes of Critically Ill Patients With Hematologic Malignancies: Prospective Multicenter Data From France and Belgium-A Groupe de Recherche Respiratoire en Reanimation Onco-Hematologique Study
Elie Azoulay et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Commensal Bacteria Control Cancer Response to Therapy by Modulating the Tumor Microenvironment
Noriho Iida et al.
SCIENCE (2013)
The Intestinal Microbiota Modulates the Anticancer Immune Effects of Cyclophosphamide
Sophie Viaud et al.
SCIENCE (2013)
The inflammatory response in sepsis
Markus Bosmann et al.
TRENDS IN IMMUNOLOGY (2013)
P. aeruginosa bloodstream infections among hematological patients: an old or new question?
Chiara Cattaneo et al.
ANNALS OF HEMATOLOGY (2012)
A comparison of critical care research funding and the financial burden of critical illness in the United States
Craig M. Coopersmith et al.
CRITICAL CARE MEDICINE (2012)
Impact of case volume on survival of septic shock in patients with malignancies
Benjamin Zuber et al.
CRITICAL CARE MEDICINE (2012)
Survival in neutropenic patients with severe sepsis or septic shock
Matthieu Legrand et al.
CRITICAL CARE MEDICINE (2012)
Immune reconstitution after hematopoietic cell transplantation
Mark Bosch et al.
CURRENT OPINION IN HEMATOLOGY (2012)
Infusional β-lactam antibiotics in febrile neutropenia: has the time come?
Iain J. Abbott et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2012)
Infections in myelodysplastic syndromes
Andrea Toma et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
Septic shock and chemotherapy-induced cytopenia: effects on microcirculation
Thomas Karvunidis et al.
INTENSIVE CARE MEDICINE (2012)
Critically ill patients with cancer and sepsis: Clinical course and prognostic factors
Maira M. Rosolem et al.
JOURNAL OF CRITICAL CARE (2012)
GENERATION OF NITRIC OXIDE AND REACTIVE OXYGEN SPECIES BY NEUTROPHILS AND MONOCYTES FROM SEPTIC PATIENTS AND ASSOCIATION WITH OUTCOMES
Sidneia Sousa Santos et al.
SHOCK (2012)
Prognostic factors for intensive care unit admission, intensive care outcome, and post-intensive care survival in patients with de novo acute myeloid leukemia: a single center experience
Peter Schellongowski et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Immunosuppression in Patients Who Die of Sepsis and Multiple Organ Failure
Jonathan S. Boomer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Bacteraemia due to multidrug-resistant Gram-negative bacilli in cancer patients: risk factors, antibiotic therapy and outcomes
C. Gudiol et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Chronic Immune Stimulation Might Act As a Trigger for the Development of Acute Myeloid Leukemia or Myelodysplastic Syndromes
Sigurdur Y. Kristinsson et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Biomarkers for bacteremia and severe sepsis in hematological patients with neutropenic fever: multivariate logistic regression analysis and factor analysis
Auni Juutilainen et al.
LEUKEMIA & LYMPHOMA (2011)
Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
Robert D. Schreiber et al.
SCIENCE (2011)
Intensive care of the cancer patient: recent achievements and remaining challenges
Elie Azoulay et al.
ANNALS OF INTENSIVE CARE (2011)
Antibiotics in critically ill patients: a systematic review of the pharmacokinetics of beta-lactams
Joao Goncalves-Pereira et al.
CRITICAL CARE (2011)
Influence of Empiric Therapy with a β-Lactam Alone or Combined with an Aminoglycoside on Prognosis of Bacteremia Due to Gram-Negative Microorganisms
J. A. Martinez et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
The post sepsis-induced expansion and enhanced function of regulatory T cells create an environment to potentiate tumor growth
Karen A. Cavassani et al.
BLOOD (2010)
Clinical characteristics and outcomes of patients with acute myelogenous leukemia admitted to intensive care: a case-control study
Amanda L. Roze des Ordons et al.
BMC CANCER (2010)
Characteristics and outcomes of patients with cancer requiring admission to intensive care units: A prospective multicenter study
Marcio Soares et al.
CRITICAL CARE MEDICINE (2010)
Early combination antibiotic therapy yields improved survival compared with monotherapy in septic shock: A propensity-matched analysis
Anand Kumar et al.
CRITICAL CARE MEDICINE (2010)
Bacteraemia due to extended-spectrum β-lactamase-producing Escherichia coli (ESBL-EC) in cancer patients: clinical features, risk factors, molecular epidemiology and outcome
Carlota Gudiol et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Sepsis biomarkers: a review
Charalampos Pierrakos et al.
CRITICAL CARE (2010)
Differentiation syndrome in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline chemotherapy: characteristics, outcome, and prognostic factors
Pau Montesinos et al.
BLOOD (2009)
A systematic review on clinical benefits of continuous administration of β-lactam antibiotics
Jason A. Roberts et al.
CRITICAL CARE MEDICINE (2009)
Continued survival gains in recent years among critically ill myeloma patients
Vincent Peigne et al.
INTENSIVE CARE MEDICINE (2009)
Incidence and clinical impact of extended-spectrum-β-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies
Enrico M. Trecarichi et al.
JOURNAL OF INFECTION (2009)
Characteristics and outcomes of cancer patients in European ICUs
Fabio Silvio Taccone et al.
CRITICAL CARE (2009)
Temporal changes in management and outcome of septic shock in patients with malignancies in the intensive care unit
Frederic Pene et al.
CRITICAL CARE MEDICINE (2008)
Evaluation of procalcitonin, neopterin, C-reactive protein, IL-6 and IL-8 as a diagnostic marker of infection in patients with febrile neutropenia
Cristina Prat et al.
LEUKEMIA & LYMPHOMA (2008)
Harmful molecular mechanisms in sepsis
Daniel Rittirsch et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy
Lionel Apetoh et al.
NATURE MEDICINE (2007)
The epidemiology of sepsis in patients with malignancy
Pajman A. Danai et al.
CHEST (2006)
Failure of neutrophil chemotactic function in breast cancer patients treated with chemotherapy
MAO Mendonça et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2006)
Outcome in severely ill patients with hematological malignancies who received intravenous chemotherapy in the intensive care unit
DD Benoit et al.
INTENSIVE CARE MEDICINE (2006)
The effect of age on the development and outcome of adult sepsis
GS Martin et al.
CRITICAL CARE MEDICINE (2006)
Intensive care in patients with newly diagnosed malignancies and a need for cancer chemotherapy
M Darmon et al.
CRITICAL CARE MEDICINE (2005)
Ceftazidime in acute myeloid leukemia patients with febrile neutropenia: Helpfulness of continuous intravenous infusion in maximizing pharmacodynamic exposure
F Pea et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Spontaneous remission in adult acute myeloid leukemia in association with systemic bacterial infection - case report and review of the literature
O Maywald et al.
ANNALS OF HEMATOLOGY (2004)
Hospitalized cancer patients with severe sepsis: analysis of incidence, mortality, and associated costs of care
MD Williams et al.
CRITICAL CARE (2004)
Association between mitochondrial dysfunction and severity and outcome of septic shock
D Brealey et al.
LANCET (2002)
Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care
DC Angus et al.
CRITICAL CARE MEDICINE (2001)
分享论文
